Evidence map›Paper›PMID 34291207›Full record

ArticleRSC chemical biology2021

A two-trick pony: lysosomal protease cathepsin B possesses surprising ligase activity.

Tyler R Lambeth, Zhefu Dai, Yong Zhang, Ryan R Julian

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tyler R LambethDepartment of Chemistry, University of California, Riverside, California, 92521, USA.
Zhefu DaiDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, Department of Chemistry, Dornsife College of Letters, Arts and Sciences, Norris Comprehensive Cancer Center, and Research Center for Liver Diseases, University of Southern California, Los Angeles, California, 90089, USA.
Yong ZhangDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, Department of Chemistry, Dornsife College of Letters, Arts and Sciences, Norris Comprehensive Cancer Center, and Research Center for Liver Diseases, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0000-0002-3132-8557
Ryan R JulianDepartment of Chemistry, University of California, Riverside, California, 92521, USA.ORCID 0000-0003-1580-8355
University of California, Riverside · USUniversity of Southern California · US

Funding

Connecting long-lived protein isomerization to lysosomal failure in Alzheimer's diseaseR01AG066626 · NIA · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI JULIAN, RYAN ROY · 2020 to 2024
$2.8M
Chemistry and Biology of ADP-Ribosylation-Dependent SignalingR35GM137901 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Yong Zhang · 2020 to 2026
$2.5M
NIA NIH HHS R01 AG066626NIGMS NIH HHS R35 GM137901
6 · The paper itself

Abstract

Cathepsin B is an important protease within the lysosome, where it helps recycle proteins to maintain proteostasis. It is also known to degrade proteins elsewhere but has no other known functionality. However, by carefully monitoring peptide digestion with liquid chromatography and mass spectrometry, we observed the synthesis of novel peptides during cathepsin B incubations. This ligation activity was explored further with a variety of peptide substrates to establish mechanistic details and was found to operate through a two-step mechanism with proteolysis and ligation occurring separately. Further explorations using varied sequences indicated increased affinity for some substrates, though all were found to ligate to some extent. Finally, experiments with a proteolytically inactive form of the enzyme yielded no ligation, indicating that the ligation reaction occurs in the same active site but in the reverse direction of proteolysis. These results clearly establish that in its native form cathepsin B can act as both a protease and ligase, although protease action eventually dominates over longer periods of time.

Identifiers

PMID34291207
PMCPMC8291735
OpenAlexW3132224045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.